Study of Omalizumab in Moderate to Severe Bronchial Asthma
Clinical trial NCT00232050 · COMPLETED
Trial details
- NCT number
- NCT00232050
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-10-01
- Primary completion
- 2005-05-01
- Enrollment
- 327
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.